Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. RANI.NASDAQ

Rani Therapeutics Holdings Inc (RANI NASDAQ) stock market data APIs

$2.87 -0.06(-2%) as of July 26, 2024
Price chart is built with Anychart

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.

Rani Therapeutics Holdings Inc Financial Data Overview

2.93
2.87
-
3.095
2.84
1.82-8.75
160 M
29 104 K
0
-0.29
0.16
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'RANI',
Type: 'Common Stock',
Name: 'Rani Therapeutics Holdings Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG011R6PZ44',
ISIN: NULL,
CUSIP: NULL,
CIK: '1856725',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-07-30',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Rani Therapeutics Holdings Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -62 735 000
  • Earnings Per Share -1.29
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Rani Therapeutics Holdings Inc Earnings via APIs

  • Latest Release 2024-05-06
  • EPS/Forecast -0.2

Get Rani Therapeutics Holdings Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Rani Therapeutics Holdings Inc latest news via APIs

RANI: 1Q:24 Results

By John Vandermosten, CFA NASDAQ:RANI READ THE FULL RANI RESEARCH REPORT Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) reported first quarter 2024 results on May 6th, 2024. However, there has been...

RANI: INITIATION – Realizing Oral Administration of Biologics

By John Vandermosten, CFA NASDAQ:RANI READ THE FULL RANI RESEARCH REPORT We are initiating coverage of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) with a target price of $12.00 per share. This v...
Do you have any questions?
support@eodhistoricaldata.com